⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NXL News
Nexalin Technology, Inc. Common Stock
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
globenewswire.com
NXLIW
NXL
Form 8-K
sec.gov
NXL
Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
globenewswire.com
NXL
RedChip's Biotech Investor Conference Replays Now Available
accessnewswire.com
SXTP
BIVI
BFRG
LTRN
NXL
Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China
globenewswire.com
NXLIW
NXL
Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21
globenewswire.com
NXLIW
NXL
Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
globenewswire.com
NXL
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
accessnewswire.com
SXTP
BIVI
BFRG
LTRN
NXL
Form 8-K
sec.gov
NXL
Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market
globenewswire.com
NXLIW
NXL